Kintara Therapeutics, Inc. (KTRA): Price and Financial Metrics

Kintara Therapeutics, Inc. (KTRA): $7.54

0.51 (-6.31%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

D

Add KTRA to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#231 of 385

in industry

KTRA Price/Volume Stats

Current price $7.54 52-week high $8.25
Prev. close $0.23 52-week low $0.08
Day low $7.17 Volume 105,720
Day high $8.25 Avg. volume 9,978,579
50-day MA $0.19 Dividend yield N/A
200-day MA $0.17 Market Cap 416.94M

KTRA Stock Price Chart Interactive Chart >


Kintara Therapeutics, Inc. (KTRA) Company Bio


Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a photodynamic therapy for the treatment of cutaneous metastatic breast cancer. The company has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China. The company was formerly known as DelMar Pharmaceuticals, Inc. and changed its name to Kintara Therapeutics, Inc. in August 2020. Kintara Therapeutics, Inc. was founded in 2009 and is headquartered in San Diego, California.


KTRA Latest News Stream


Event/Time News Detail
Loading, please wait...

KTRA Latest Social Stream


Loading social stream, please wait...

View Full KTRA Social Stream

KTRA Price Returns

1-mo N/A
3-mo -4.38%
6-mo 28.23%
1-year -36.28%
3-year -99.41%
5-year -99.59%
YTD 27.02%
2023 -97.54%
2022 -72.98%
2021 -60.16%
2020 85.59%
2019 -79.71%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!